Condition

FSGS clinical trials and research

• 8Clinical trials
• 21Countries

Newest FSGS clinical trials

All recruiting trials (8)

• Safety, tolerability, and how the body handles SK-09

  This trial will test single and repeated oral doses of SK-09 for safety and to see how the body processes them in healthy adults aged 18–55.

  Recruiting Phase 1 Consun Pharmaceutical Group · Herston, Queensland · NCT07267026

• APL2 in FSGS: a two-stage study to see if twice-weekly injections help adults and teens

  This study tests if twice-weekly subcutaneous APL2 can help people with FSGS, starting with a phase 2, single-arm portion and moving to a phase 3, randomized, placebo-controlled portion.

  Recruiting at 2 sites Phase 2/3 Apellis Pharmaceuticals, Inc. · Chicago, Illinois and 1 other locations · NCT07213960

• Atacicept for multiple autoimmune glomerular diseases

  This will test whether weekly injections of atacicept can lower protein in the urine and help preserve kidney function in people aged 10 and older with IgA nephropathy, primary membranous nephropathy, or nephrotic syndromes such as MCD and FSGS.

  Recruiting Phase 2 Vera Therapeutics, Inc. · Brisbane, California · NCT06983028

• Observational study on kidney transplant recurrence in FSGS and MCD

  This study is looking at patients with kidney diseases called FSGS and MCD who have had or will have a kidney transplant to see how often these diseases come back afterward.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT05650619

• Transplanting stem cells and kidneys from the same donor to prevent rejection

  This study is testing if giving patients stem cells and a kidney from the same donor can help prevent kidney rejection without needing lifelong medication to suppress their immune system.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT05508009

• Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome

  This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT05505500

• Evaluating DMX-200 for treating FSGS in patients on ARBs

  This study is testing if a new medication called DMX-200 can help people with FSGS who are already taking another heart medication feel better and improve their kidney function.

  Recruiting at 28 sites Phase 3 Dimerix Bioscience Pty Ltd · Birmingham, Alabama and 219 other locations · NCT05183646

• NEPTUNE Match: Personalized matching of patients to kidney treatment options

  This project will try a system that matches people in the NEPTUNE cohort who have nephrotic syndromes or related kidney diseases with suitable clinical trials and shares those matches with patients and their doctors.

  Recruiting at 15 sites University of Michigan · Atlanta, Georgia and 15 other locations · NCT04571658

Related topics

Quick answers

How many FSGS clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 21 countries. The most sites are in United States (7 trials), Australia (2 trials), Argentina (1 trial), Brazil (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1/2: 1, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →